Deferiprone and Appetite decreased - a phase IV clinical study of FDA data
Appetite decreased is reported only by a few people who take Deferiprone.
The phase IV clinical study analyzes which people take Deferiprone and have Appetite decreased. It is created by eHealthMe based on reports of 362 people who have side effects while taking Deferiprone from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
362 people reported to have side effects when taking Deferiprone.
Among them, 4 people (1.1%) have Appetite decreased.
What is Deferiprone?
Deferiprone has active ingredients of deferiprone. eHealthMe is studying from 362 Deferiprone users for its effectiveness, alternative drugs and more.
What is Appetite decreased?
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 4,198 drugs and 4,243 conditions by eHealthMe.
Number of Deferiprone and Appetite decreased reports submitted per year:
Gender of people who have Appetite decreased when taking Deferiprone *:
- female: 75 %
- male: 25 %
Age of people who have Appetite decreased when taking Deferiprone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 75 %
- 50-59: 25 %
- 60+: 0.0 %
Common drugs people take besides Deferiprone *:
- Oxycodone: 4 people, 100.00%
- Oxycontin: 3 people, 75.00%
- Oxbryta: 3 people, 75.00%
- Lisinopril: 1 person, 25.00%
- Jadenu: 1 person, 25.00%
- Hydrea: 1 person, 25.00%
- Folic Acid: 1 person, 25.00%
- Flexeril: 1 person, 25.00%
- Ferriprox: 1 person, 25.00%
- Exjade: 1 person, 25.00%
Common side effects people have besides Appetite decreased *:
- Nausea And Vomiting: 3 people, 75.00%
- Nausea (feeling of having an urge to vomit): 3 people, 75.00%
- Weakness: 1 person, 25.00%
- Mood Swings (an extreme or rapid change in mood): 1 person, 25.00%
- Dizziness: 1 person, 25.00%
- Crying: 1 person, 25.00%
- Ammonia Increased: 1 person, 25.00%
Common conditions people have *:
- Iron Overload: 3 people, 75.00%
- Haemochromatosis (body to absorb more iron than usual from food): 1 person, 25.00%
* Approximation only. Some reports may have incomplete information.
Do you take Deferiprone and have Appetite decreased?Check whether Appetite decreased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Appetite decreased and when was it recovered:
Expand to all the drugs that have ingredients of deferiprone:
Alternative drugs to, pros and cons of Deferiprone:
- Deferiprone (362 reports)
Appetite decreased treatments and more:
- Appetite decreased (223,210 reports)
COVID vaccines that are related to Appetite decreased:
- Appetite decreased in Moderna COVID Vaccine
- Appetite decreased in Pfizer BioNTech Covid Vaccine
- Appetite decreased in Johnson and Johnson Covid Vaccine
Common drugs associated with Appetite decreased:
All the drugs that are associated with Appetite decreased:
- Appetite decreased (4,198 drugs)
Common conditions associated with Appetite decreased:
All the conditions that are associated with Appetite decreased:
- Appetite decreased (4,243 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on deferiprone (the active ingredients of Deferiprone) and Deferiprone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bentyl vs. Endep - 2 seconds ago
- Naprosyn and Demyelination - 3 seconds ago
- Hypothalamo-Pituitary Disorder and Pituitary Tumor Recurrent - 11 seconds ago
- Zomig and Oral Disorder - 14 seconds ago
- Cimzia and Klor-Con drug interaction - 19 seconds ago
- Insulin and Productive Cough - 25 seconds ago
- Cymbalta and Ziana drug interaction - 30 seconds ago
- How effective is Aspirin for Blood Clots? - 34 seconds ago
- Abdominal Bloating in B Complex Vitamin, how severe and when it was recovered? - 34 seconds ago
- Vagifem and Sleep Apnea Syndrome - 39 seconds ago